Anti-HIV agents. New drugs--hope and  a degree of caution.
D003510:Cyclohexanes / Q000009:adverse effects / Q000627:therapeutic use*; D023581:HIV Fusion Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy*; D019428:HIV Integrase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D000077592:Maraviroc; D009369:Neoplasms / Q000139:chemically induced; D009930:Organic Chemicals / Q000009:adverse effects / Q000627:therapeutic use*; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium; D014230:Triazoles / Q000009:adverse effects / Q000627:therapeutic use*
D003510:Cyclohexanes; D023581:HIV Fusion Inhibitors; D019428:HIV Integrase Inhibitors; D009930:Organic Chemicals; D011760:Pyrrolidinones; D014230:Triazoles; D000068898:Raltegravir Potassium; D000077592:Maraviroc